Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growthAnthony M. Barsotti, Robert A. Rollins, Veronica Diesl et al.|Oncotarget|2015Cited by 46
Discovery of 5-Chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1<i>H</i>)-one (BMS-903452), an Antidiabetic Clinical Candidate Targeting GPR119Dean A. Wacker, Jeffrey A. Robl, Ying Wang et al.|Journal of Medicinal Chemistry|2014Cited by 46
Abstract 5144: Epigenetic reprogramming by tumor-derived EZH2 gain of function mutants leads to aggressive 3D-cell morphologies in both epithelial and melanoma cellsRobert A. Rollins, Dominique Verhelle, Anthony M. Barsotti et al.|Cancer Research|2014Cited by 0